日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases

TUXEDO-1 II期试验（曲妥珠单抗-德鲁替康治疗HER2阳性伴活动性脑转移乳腺癌患者）的最终结果分析

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noae123
Bartsch, Rupert; Berghoff, Anna Sophie; Furtner, Julia; Marhold, Maximilian; Bergen, Elisabeth Sophie; Roider-Schur, Sophie; Mair, Maximilian Johannes; Starzer, Angelika Martina; Forstner, Heidrun; Rottenmanner, Beate; Aretin, Marie-Bernadette; Dieckmann, Karin; Bago-Horvath, Zsuzsanna; Haslacher, Helmuth; Widhalm, Georg; Ilhan-Mutlu, Aysegül; Minichsdorfer, Christoph; Fuereder, Thorsten; Szekeres, Thomas; Oehler, Leopold; Gruenberger, Birgit; Pfeiler, Georg; Singer, Christian; Weltermann, Ansgar; Berchtold, Luzia; Preusser, Matthias
肿瘤
HER2
肿瘤免疫
神经科学
乳腺癌
发表日期：2024
文献求助 收藏

Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patients

预测晚期癌症患者非计划急诊就诊后90天的死亡风险

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-024-08919-z
Jeryczynski, Georg; Krall, Christoph; Pasalic, Sabina; Huber, Dominikus; Cacioppo, Filippo; Bartsch, Rupert; Fuereder, Thorsten; Laggner, Anton; Preusser, Matthias; Minichsdorfer, Christoph
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

COVID-19 大流行期间癌症患者口服阿奇霉素预防性治疗（OnCoVID）：一项随机、单盲、安慰剂对照的 II 期试验

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-023-00487-x
Mair, Maximilian J; Maj-Hes, Agnieszka; Nussbaumer-Pröll, Alina; Puhr, Rainer; Christenheit, Agnieszka; Troch, Marlene; Puhr, Hannah C; Starzer, Angelika M; Steindl, Ariane; Eberl, Sabine; Haslacher, Helmuth; Perkmann, Thomas; Minichsdorfer, Christoph; Prager, Gerald W; Lamm, Wolfgang W; Berghoff, Anna S; Kiesewetter, Barbara; Zeitlinger, Markus; Preusser, Matthias; Raderer, Markus
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

曲妥珠单抗德鲁替康治疗伴脑转移的HER2阳性乳腺癌：一项单臂II期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-022-01935-8
Bartsch, Rupert; Berghoff, Anna Sophie; Furtner, Julia; Marhold, Maximilian; Bergen, Elisabeth Sophie; Roider-Schur, Sophie; Starzer, Angelika Martina; Forstner, Heidrun; Rottenmanner, Beate; Dieckmann, Karin; Bago-Horvath, Zsuzsanna; Haslacher, Helmuth; Widhalm, Georg; Ilhan-Mutlu, Aysegül; Minichsdorfer, Christoph; Fuereder, Thorsten; Szekeres, Thomas; Oehler, Leopold; Gruenberger, Birgit; Singer, Christian F; Weltermann, Ansgar; Puhr, Rainer; Preusser, Matthias
肿瘤
HER2
肿瘤免疫
神经科学
乳腺癌
发表日期：2022
文献求助 收藏

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

在晚期和转移性头颈部鳞状细胞癌患者中，对PD-1免疫检查点抑制剂有反应者和无反应者的DNA甲基化谱存在差异。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003420
Starzer, Angelika Martina; Heller, Gerwin; Tomasich, Erwin; Melchardt, Thomas; Feldmann, Katharina; Hatziioannou, Teresa; Traint, Stefan; Minichsdorfer, Christoph; Schwarz-Nemec, Ursula; Nackenhorst, Maja; Müllauer, Leonhard; Preusser, Matthias; Berghoff, Anna Sophie; Fuereder, Thorsten
肿瘤
表观遗传
肿瘤免疫
DNA甲基化
细胞生物学
PD-1
免疫/内分泌
发表日期：2022
文献求助 收藏

Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18

ABCSG-18 研究的一项事后分析：在接受辅助地诺单抗或安慰剂治疗的激素受体阳性早期乳腺癌绝经后患者中，伴随他汀类药物治疗的效果

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100426
Minichsdorfer, C; Fuereder, T; Leutner, M; Singer, C F; Kacerovsky-Strobl, S; Egle, D; Greil, R; Balic, M; Fitzal, F; Pfeiler, G; Frantal, S; Bartsch, R; Gnant, M
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

在接受抗PD-1/PD-L1治疗的真实世界癌症患者人群中，血清参数作为预后生物标志物

期刊:
影响因子:
doi:10.1080/07853890.2022.2070660
Minichsdorfer, Christoph; Gleiss, Andreas; Aretin, Marie-Bernadette; Schmidinger, Manuela; Fuereder, Thorsten
PD-L1
肿瘤
肿瘤免疫
PD-1
发表日期：2022
文献求助 收藏

Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centre

新冠疫情封锁对高流量癌症中心常规肿瘤科诊疗与急诊护理的影响

期刊:European Journal of Clinical Investigation
影响因子:3.6
doi:10.1111/eci.13623
Minichsdorfer, Christoph; Jeryczynski, Georg; Krall, Christoph; Achhorner, Alina Magdalena; Caraan, Ariane; Pasalic, Sabina; Reininger, Katharina; Wagner, Christina; Bartsch, Rupert; Preusser, Matthias; Laggner, Anton; Raderer, Markus; Fuereder, Thorsten
微生物学
新冠
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

既往未接受过癌症治疗的患者对癌症治疗目标的期望和认知。EXPECT试验

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-020-05826-x
Minichsdorfer, Christoph; Zeller, O; Kirschbaum, M; Berghoff, A S; Bartsch, R
肿瘤
肿瘤免疫
神经科学
发表日期：2021
文献求助 收藏

Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management

青少年和青年（AYA）初始局限性及转移性骨肉瘤：一项回顾性单中心副作用管理分析

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.12269
Minichsdorfer, Christoph; Steinbrecher, Oskar; KÖlz, Marita; Schmid, Maximilian; Raderer, Markus; Brodowicz, Thomas; Lamm, Wolfgang
骨肉瘤
发表日期：2021
文献求助 收藏